Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (12): 1332-1338.

Previous Articles     Next Articles

Advances of analysis technology and data processing in metabonomics study

REN Hong-can1, WANG Cuang-ji1,2, A Ji-ye1, HAO Hai-ping1, SUN Jian-guo1, ZHA Wei-bin1, YAN Bei1   

  1. 1Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210038, Jiangsu, China;
    2Department of Medical Biosciences, Clinical Chemistry, Umea University, SE 90185, Umea, Sweden
  • Received:2007-07-02 Revised:2007-11-05 Published:2020-11-10

Abstract: Metabonomics takes great progress withthe development of analysis technology and biometrics. Asa new member of omicssciences, metabonomics hasshown potentials in drug development, screening of drugtoxicity, and disease diagnosis for its sensitive, rapid,quantitative, noninvasive, and systemic characteristics.The key aspects of metabonomics, including preparationof samples, analysis technology, principle of data pro-cessing, traectory of metabolome, identification of bio-markers and indexation of metabolic pathway are reviewed in this article. The advantages and disadvantages of sev-eral popular analysis technologies for metabonomics areevaluated. Also the development prospect of metabonom-ics is expected.

Key words: metabonomics, nuclear magnetic reso-nance, GC/MS, LC/MS, biomarkers, multivariate analy-sis, patterm recognition, metabolic pathway

CLC Number: